These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7354241

  • 1. The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women.
    Gallagher JC, Riggs BL, Jerpbak CM, Arnaud CD.
    J Lab Clin Med; 1980 Mar; 95(3):373-85. PubMed ID: 7354241
    [Abstract] [Full Text] [Related]

  • 2. Effect of age on circulating immunoreactive and bioactive parathyroid hormone levels in women.
    Forero MS, Klein RF, Nissenson RA, Nelson K, Heath H, Arnaud CD, Riggs BL.
    J Bone Miner Res; 1987 Oct; 2(5):363-6. PubMed ID: 3455620
    [Abstract] [Full Text] [Related]

  • 3. Age-related rise in parathyroid hormone in man: the use of intact and midmolecule antisera to distinguish hormone secretion from retention.
    Young G, Marcus R, Minkoff JR, Kim LY, Segre GV.
    J Bone Miner Res; 1987 Oct; 2(5):367-74. PubMed ID: 3455621
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid function in primary osteoporosis.
    Riggs BL, Arnaud CD, Jowsey J, Goldsmith RS, Kelly PJ.
    J Clin Invest; 1973 Jan; 52(1):181-4. PubMed ID: 4734167
    [Abstract] [Full Text] [Related]

  • 5. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
    Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF.
    J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
    [Abstract] [Full Text] [Related]

  • 6. PTH bioactivity in osteoporosis.
    Saphier PW, Stamp TC, Kelsey CR, Loveridge N.
    Bone Miner; 1987 Oct; 3(1):75-83. PubMed ID: 3505195
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
    Gautvik KM, Gautvik VT, Halvorsen JF.
    Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372
    [Abstract] [Full Text] [Related]

  • 8. Age-related changes in serum immunoreactive parathyroid hormone and its biological action in healthy men and women.
    Endres DB, Morgan CH, Garry PJ, Omdahl JL.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):724-31. PubMed ID: 2821053
    [Abstract] [Full Text] [Related]

  • 9. [Osteoporosis at high remodeling and parathyroid function. Histo-biological confrontations (author's transl)].
    Joly R, Chapuy MC, Alexandre C, Meunier PJ.
    Pathol Biol (Paris); 1980 Sep; 28(7):417-24. PubMed ID: 6999427
    [Abstract] [Full Text] [Related]

  • 10. Reduced parathyroid hormone response to peroral phosphate in osteoporotic patients.
    Ittner J, Dambacher MA, Muff R, Rüegsegger P, Trechsel U, Fischer JA.
    Miner Electrolyte Metab; 1986 Sep; 12(3):199-203. PubMed ID: 3014300
    [Abstract] [Full Text] [Related]

  • 11. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A, Nastić-Mirić D, Milikić V, Babić D, Pejcić I, Kostić M, Paripović V, Jovanović O, Kruscić D, Mancić J.
    Srp Arh Celok Lek; 1996 Sep; 124(9-10):227-31. PubMed ID: 9102853
    [Abstract] [Full Text] [Related]

  • 12. Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia.
    Kazama JJ, Omori T, Ei I, Ei K, Oda M, Maruyama H, Narita I, Gejyo F, Shigematsu T, Fukagawa M.
    Clin Exp Nephrol; 2003 Jun; 7(2):144-9. PubMed ID: 14586733
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone: radioimmunoassay and clinical interpretation.
    Hawker CD.
    Ann Clin Lab Sci; 1975 Jun; 5(5):383-98. PubMed ID: 1180481
    [Abstract] [Full Text] [Related]

  • 14. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans.
    Marcus R, Madvig P, Young G.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):223-30. PubMed ID: 6319444
    [Abstract] [Full Text] [Related]

  • 15. [Osteoporosis at high remodeling and parathyroid function. Histo-biological confrontations (author's transl)].
    Joly R, Chapuy MC, Alexandre C, Meunier PJ.
    Sem Hop; 1984 Feb; 57(5-6):266-73. PubMed ID: 6259748
    [Abstract] [Full Text] [Related]

  • 16. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH, Roy L, Lepage R, Gascon-Barré M, D'Amour P.
    Miner Electrolyte Metab; 1997 Feb; 23(1):25-32. PubMed ID: 9058366
    [Abstract] [Full Text] [Related]

  • 17. A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D.
    Riggs BL, Gallagher JC, DeLuca HF, Edis AJ, Lambert PW, Arnaud CD.
    Mayo Clin Proc; 1978 Nov; 53(11):701-6. PubMed ID: 713601
    [Abstract] [Full Text] [Related]

  • 18. Normalization of intraoperative parathyroid hormone does not predict normal postoperative parathyroid hormone levels.
    Starr FL, DeCresce R, Prinz RA.
    Surgery; 2000 Dec; 128(6):930-5;discussion 935-6. PubMed ID: 11114626
    [Abstract] [Full Text] [Related]

  • 19. [Relationship between serum 1,25-dihydroxyvitamin D and bone loss in postmenopausal women].
    Zhu G, Wang H, Xu P.
    Zhonghua Yi Xue Za Zhi; 2001 Dec 10; 81(23):1443-6. PubMed ID: 11930618
    [Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 10; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.